Treatment | Page 105 of 465

Breast Cancer :: Racial differences in severity of breast cancer presentation confirmed

African-American women are diagnosed with more advanced breast cancer than Caucasians, according to a new, single hospital study. Published in the August 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study analyzed demographic and breast cancer data from a single institution?s registry, and confirmed that African-Americans are more likely to present with later stage and higher grade tumors compared to Caucasians.

Tuberculosis :: Statement from TB patient Andrew Speaker

Andrew Speaker writes, I am incredibly relieved that the multiple test results made public show that I don’t have extensively drug resistant tuberculosis.

Chromosome :: Double identities lie behind chromosome disorders

Chromosome disorders in sex cells cause infertility, miscarriage and irregular numbers of chromosomes (aneuploidy) in neonates. A new study from Karolinska Institutet published in the scientific journal Nature Genetics shows how chromosome disorders can arise when sex cells are formed.

Prostate Cancer :: Hormone inhibitor promising for hard-to-treat prostate cancer

For prostate cancer patients whose tumors have continued to grow despite medical or surgical castration, a new drug candidate that inhibits production of male hormones anywhere in the body is showing promise in early trials.

High Blood Pressure :: Dark chocolate bite lowers high blood pressure

Daily bite of dark chocolate may reduce high blood pressure in hypertensive patients. Eating about 30 calories a day of dark chocolate was associated with a lowering of blood pressure revealed in a study.

Chemotherapy :: Analysis confirms benefits of combining trastuzumab and chemotherapy

A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.

Asthma :: Drug coverage expanded for patients to breathe easier, BC

Patients who experience severe breathing conditions such as chronic bronchitis and emphysema will benefit from PharmaCare coverage for the medication tiotropium, also known as Spiriva, announced Health Minister George Abbott.

Liver Tumor :: MediGene cancer-fighting virus shows promise in early clinical trial

A virus that has been specifically designed by scientists to be safe to normal tissue but deadly to cancer is showing early promise in a preliminary study, researchers said at the ESMO Conference Lugano (ECLU), Switzerland.

HIV :: PREZISTA Phase III Study meets primary objective in HIV patients

Results from a Phase 3 head-to-head study showed that a significantly greater percent (77 percent) of treatment-experienced HIV-1 infected adults* taking Prezista? (darunavir)/ritonavir, with an optimised background regimen (OBR) of antiretroviral agents, reached a viral load of less than 400 copies/mL at week 48, compared to 68 percent of patients taking the widely prescribed medication lopinavir/ritonavir, with OBR, in a per-protocol analysis (95 percent confidence interval 2-16). In addition, significantly more patients receiving darunavir/r in this study reached an undetectable viral load (<50 copies/mL) compared to patients taking lopinavir/r (71 percent vs. 60 percent).

Chikungunya :: Doctors urged to be alert for chikungunya infection

Fever, arthritis, and other symptoms occurring in people to who have recently traveled to islands in the Indian Ocean may signal infection with an imported virus called “chikungunya,” reports a study in the May/June issue of the journal Medicine?, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.